Abstract
Cancer is one of the leading causes of mortality in developed countries such as the USA. In 1998, there were more than 280,000 and 250,000 cancer related deaths in males and females, respectively. In males, lung and prostate cancers accounted for almost half of these deaths, whereas in females, lung and breast cancers were the leading causes of cancer mortalities. Therefore, the study of cancer has been of the utmost importance to patients, doctors, and researchers alike. A variety of cellular processes occur in the precancerous cells that contribute to the development and progression to cancer. Not surprisingly, all of these cellular processes have been targeted for anticancer therapy. A novel serpin, maspin, has demonstrated a robust effect on a variety of these cancer progression steps. A number of studies have shown that maspin inhibits angiogenesis and tumor cell growth and invasion both in vitro and in vivo. In addition, maspin promotes cell adhesion to the basement membrane and extracellular matrix components. Efforts underway to understand the molecular mechanisms involved in the diverse functions influenced by maspin have yielded promising results and shed light on the cancer pathways.
Keywords: Maspin, Metastasis, Angiogenesis
Current Molecular Medicine
Title: Role of Maspin in Tumor Metastasis and Angiogenesis
Volume: 3 Issue: 7
Author(s): Jeremy S. Schaefer and Ming Zhang
Affiliation:
Keywords: Maspin, Metastasis, Angiogenesis
Abstract: Cancer is one of the leading causes of mortality in developed countries such as the USA. In 1998, there were more than 280,000 and 250,000 cancer related deaths in males and females, respectively. In males, lung and prostate cancers accounted for almost half of these deaths, whereas in females, lung and breast cancers were the leading causes of cancer mortalities. Therefore, the study of cancer has been of the utmost importance to patients, doctors, and researchers alike. A variety of cellular processes occur in the precancerous cells that contribute to the development and progression to cancer. Not surprisingly, all of these cellular processes have been targeted for anticancer therapy. A novel serpin, maspin, has demonstrated a robust effect on a variety of these cancer progression steps. A number of studies have shown that maspin inhibits angiogenesis and tumor cell growth and invasion both in vitro and in vivo. In addition, maspin promotes cell adhesion to the basement membrane and extracellular matrix components. Efforts underway to understand the molecular mechanisms involved in the diverse functions influenced by maspin have yielded promising results and shed light on the cancer pathways.
Export Options
About this article
Cite this article as:
Schaefer S. Jeremy and Zhang Ming, Role of Maspin in Tumor Metastasis and Angiogenesis, Current Molecular Medicine 2003; 3 (7) . https://dx.doi.org/10.2174/1566524033479519
DOI https://dx.doi.org/10.2174/1566524033479519 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapeutic Implications of Gene Deletion of Ligands and Receptors of Members of TNF Superfamily
Medicinal Chemistry Reviews - Online (Discontinued) Unveiling Role of MicroRNAs as Treatment Strategy and Prognostic Markers in Triple Negative Breast Cancer
Current Pharmaceutical Biotechnology Dendritic Cell Immunotherapy for Melanoma
Reviews on Recent Clinical Trials Synthesis and Stereochemistry-Activity Relationship of Chiral Thiourea Derivatives as Potential Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Mechanisms of Activation and Key Roles of SGK3 Under Physiological Conditions and in Prostate and Breast Cancer
Current Signal Transduction Therapy Immunological Aspects of Adult T-Cell Leukemia/Lymphoma (ATLL), a Possible Neoplasm of Regulatory T-Cells
Current Immunology Reviews (Discontinued) Depleted Uranium and Human Health
Current Medicinal Chemistry Autofluorescence of Breast Cancer Proteins
Current Metabolomics Subject Index To Volume 9
Current Medicinal Chemistry Epidemiology of NHP-Drug Interactions: Identification and Evaluation
Current Drug Metabolism Microbiome in Chronic Obstructive Pulmonary Disease: Role of Natural Products Against Microbial Pathogens
Current Medicinal Chemistry Natural Polyphenols and their Synthetic Analogs as Emerging Anticancer Agents
Current Drug Targets Impact of CYP2D6 Genetic Variation on the Response of the Cardiovascular Patient to Carvedilol and Metoprolol
Current Drug Metabolism Applications of Recombinant Adenovirus-p53 Gene Therapy for Cancers in the Clinic in China
Current Gene Therapy Small Non-Coding RNAs as Biomarkers
Recent Patents on Biomarkers Tyrosine Kinases as Targets for Anti-Inflammatory Therapy
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Triple Negative Breast Cancer: How Neurokinin-1 Receptor Antagonists Could Be Used as a New Therapeutic Approach
Mini-Reviews in Medicinal Chemistry Abundance and Diversity of GI Microbiota Rather than IgG<sub>4</sub> Levels Correlate with Abdominal Inconvenience and Gut Permeability in Consumers Claiming Food Intolerances
Endocrine, Metabolic & Immune Disorders - Drug Targets Systemic Therapies for Pancreatic Cancer - The Role of Pharmacogenetics
Current Drug Targets Therapeutic Antibodies and Other Proteins Obtained by Molecular Display Technologies
Recent Patents on Biotechnology